Abstract:BACKGROUND & OBJECTIVE:Recently, chitosan, as a nonviral vehicle for transferring DNA molecules into the cells, has attracted much attention because of its cationic properties. This study was to investigate characteristics and transfection activity of chitosan-pDNA microparticles, and confirm the feasibility of chitosan as gene therapy vehicle, which may be employed in further in vivo study.METHODS:Plasmid DNAs were amplified in Eschericha Coli JM109 with transfection of enhanced green fluorescence protein (EGFP) gene, and isolated according to the protocol of Qiagen plasmid midi kit. Chitosan-pDNA microparticles were prepared by the coacervation method, and observed under transmission electronic microscope. In vitro releasing experiment and ultraviolet spectrophotometry were used to measure DNA loading capacity and loading efficiency. The location of pDNA in the microparticles was analyzed by gel retardation assay. Transfection efficiency of chitosan-pDNA microparticles was evaluated by detecting gene expression of EGFP in HEK293 cells after transfection.RESULTS:Chitosan-pDNA microparticles were global, and the size ranged 100-200 nm, with the average of (138 +/- 43) nm. DNA loading capacity and loading efficiency of the microparticles were (46.8 +/- 9.0)% and 100%, respectively. Gel retardation assay confirmed that DNA was wholly encapsulated in the microparticles. In vitro study revealed that the release of DNA from chitosan-pDNA microparticles included two-step process, namely burst effect with a slow second phase. Most of DNA could be released at the time of 48 h. In vitro transfection results indicated that chitosan could efficiently deliver pEGFP into HEK293 cells and stably express green florescence protein.CONCLUSIONS:Chitosan can efficiently transfer target DNA molecules into mammalian cells, continuously release DNA, and stably express DNA. It can be potentially employed as a gene therapy vehicle.

Chemical modification of chitosan as a gene carrier in vitro and in vivo

Chemical modification of chitosan for efficient gene therapy.

Chemical Modification of Chitosan As a Gene Transporter

Receptor-Mediated Gene Delivery Using Chitosan Derivatives in Vitro and in Vivo

Progress and Prospects of Chitosan and Its Derivatives As Non-Viral Gene Vectors in Gene Therapy

A Review of Chitosan in Gene Therapy: Developments and Challenges.

Recent Progress in Biomedical Applications of Chitosan Derivatives as Gene Carrier

Chitosan and Its Derivatives—a Promising Non-Viral Vector for Gene Transfection

Ph‐sensitive Modification of Chitosan As a Gene Carrier among Marine Biomaterials

Chitosan-graft-spermine as a gene carrier in vitro and in vivo

Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection

Exploring modified chitosan-based gene delivery technologies for therapeutic advancements

Study on Surface Modification and Transfection of Gene-chitosan Nanoparticles

Advance in the Study of Chitosan and its Derivatives as Non-Viral Vectors

[Feasibility of Chitosan As Gene Therapy Vehicle].

Efficient gene delivery using chitosan-polyethylenimine hybrid systems.

Synthesis and cell activity of novel galactosylated chitosan as a gene carrier.

Synthesis and Evaluation of Novel Chitosan Derivatives for Gene Delivery

Galactosylation of Chitosan-Graft-Spermine As a Gene Carrier for Hepatocyte Targeting in Vitro and in Vivo

Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery.

Exploring Advantages/Disadvantages and Improvements in Overcoming Gene Delivery Barriers of Amino Acid Modified Trimethylated Chitosan